Artwork
iconShare
 
Manage episode 520147111 series 3702379
Content provided by American Society of Addiction Medicine. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American Society of Addiction Medicine or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

States With Substantial Increases In Buprenorphine Uptake Did So With Increased Medicaid Prescribing, 2018–24

Health Affairs

Multiple federal policy changes since 2018 intended to increase buprenorphine prescribing in response to a persistent treatment gap for opioid use disorder (OUD) in the US. Anticipated national increases did not occur, but highly variable state-level trends provide important insights. This study used IQVIA data to examine all-payer and per payer prescribing across states during the period 2018–24.  Researchers found that highly disparate state-level changes suggest that federal policy impacts were mediated by state-specific factors. Medicaid’s key role in driving overall prescribing highlights the public health urgency of maintaining expansions and sustaining enrollment for the single adult population.

Read this issue of the ASAM Weekly

Subscribe to the ASAM Weekly

Visit ASAM

  continue reading

100 episodes